Thrombolytic treatment in a patient with antiphospholipid syndrome APS developing renal infarction

Ugan Y., Dogru A., Sahin M., Tunc S. E.

ZEITSCHRIFT FUR RHEUMATOLOGIE, vol.75, no.8, pp.838-840, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 75 Issue: 8
  • Publication Date: 2016
  • Doi Number: 10.1007/s00393-016-0154-7
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.838-840
  • Süleyman Demirel University Affiliated: Yes


Antiphospholipid syndrome (APS), a leading entity in acquired thrombophilia, is characterized by recurrent thrombosis, morbidity in pregnancy and presence of antiphospholipid antibodies (APA). Although the etiopathogenesis is unclear, APA against negatively charged phospholipids and phospholipid-protein complexes are held responsible for the clinical picture. In case of acute thrombosis due to APS, thrombolytic therapy is not a commonly administered treatment option. Here, we present a case with acute thrombosis in the left renal artery showing partial response to thrombolytic therapy.